Neostigmine Treatment of Paralytic Ileus in Critically Ill Patients.
10.17479/jacs.2017.7.2.78
- Author:
Nak Jun CHOI
1
;
Tae Hyun KIM
;
Suk Kyung HONG
Author Information
1. Division of Trauma and Surgical Critical Care, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. skhong94@amc.seoul.kr
- Publication Type:Case Report
- Keywords:
Paralytic ileus;
Critical illness;
Neostigmine
- MeSH:
Aged, 80 and over;
Clostridium difficile;
Colitis;
Critical Illness*;
Diagnosis;
Gastrointestinal Tract;
Humans;
Ileus;
Intensive Care Units;
Intestinal Pseudo-Obstruction*;
Neostigmine*;
Patients' Rooms;
Physical Examination
- From:
Journal of Acute Care Surgery
2017;7(2):78-82
- CountryRepublic of Korea
- Language:English
-
Abstract:
Paralytic ileus is a common complication in critically ill patients, and can affect all parts of the gastrointestinal tract. We report a case of paralytic ileus that improved after neostigmine administration. An 80-year-old man was transferred to the intensive care unit after a diagnosis of severe colitis due to Clostridium difficile infection while under conservative treatment for paralytic ileus . The patient's colitis resolved but the ileus did not. This prompted neostigmine administration, resulting in remarkable improvements in the abdominal physical examination and radiographic images. Bowel movements recovered, oral feeding was restarted, and the patient was transferred back to the general ward.
